200 related articles for article (PubMed ID: 32813515)
1. Platinum-Based Combination Therapy: Molecular Rationale, Current Clinical Uses, and Future Perspectives.
Yu C; Wang Z; Sun Z; Zhang L; Zhang W; Xu Y; Zhang JJ
J Med Chem; 2020 Nov; 63(22):13397-13412. PubMed ID: 32813515
[TBL] [Abstract][Full Text] [Related]
2. Nanocarriers for delivery of platinum anticancer drugs.
Oberoi HS; Nukolova NV; Kabanov AV; Bronich TK
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1667-85. PubMed ID: 24113520
[TBL] [Abstract][Full Text] [Related]
3. Platinum-based drugs: past, present and future.
Dilruba S; Kalayda GV
Cancer Chemother Pharmacol; 2016 Jun; 77(6):1103-24. PubMed ID: 26886018
[TBL] [Abstract][Full Text] [Related]
4. Dual-drug delivery of curcumin and platinum drugs in polymeric micelles enhances the synergistic effects: a double act for the treatment of multidrug-resistant cancer.
Scarano W; de Souza P; Stenzel MH
Biomater Sci; 2015 Jan; 3(1):163-74. PubMed ID: 26214199
[TBL] [Abstract][Full Text] [Related]
5. Changing the paradigm in the treatment of platinum-sensitive recurrent ovarian cancer: from platinum doublets to nonplatinum doublets and adding antiangiogenesis compounds.
Monk BJ; Coleman RL
Int J Gynecol Cancer; 2009 Dec; 19 Suppl 2():S63-7. PubMed ID: 19955917
[TBL] [Abstract][Full Text] [Related]
6. Polymeric drug delivery of platinum-based anticancer agents.
Haxton KJ; Burt HM
J Pharm Sci; 2009 Jul; 98(7):2299-316. PubMed ID: 19009590
[TBL] [Abstract][Full Text] [Related]
7. The development of platinum compounds and their possible combination.
Pasetto LM; D'Andrea MR; Brandes AA; Rossi E; Monfardini S
Crit Rev Oncol Hematol; 2006 Oct; 60(1):59-75. PubMed ID: 16806960
[TBL] [Abstract][Full Text] [Related]
8. Novel platinum compounds and nanoparticles as anticancer agents.
Sarkar A
Pharm Pat Anal; 2018 Jan; 7(1):33-46. PubMed ID: 29227198
[TBL] [Abstract][Full Text] [Related]
9. Revisiting Platinum-Based Anticancer Drugs to Overcome Gliomas.
Jeon J; Lee S; Kim H; Kang H; Youn H; Jo S; Youn B; Kim HY
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065991
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy.
Makovec T
Radiol Oncol; 2019 Mar; 53(2):148-158. PubMed ID: 30956230
[TBL] [Abstract][Full Text] [Related]
11. Application of liposomal technologies for delivery of platinum analogs in oncology.
Liu D; He C; Wang AZ; Lin W
Int J Nanomedicine; 2013; 8():3309-19. PubMed ID: 24023517
[TBL] [Abstract][Full Text] [Related]
12. Nanocapsules of platinum anticancer drugs: development towards therapeutic use.
Bryde S; de Kroon AI
Future Med Chem; 2009 Nov; 1(8):1467-80. PubMed ID: 21426060
[TBL] [Abstract][Full Text] [Related]
13. Research progress in modern structure of platinum complexes.
Bai L; Gao C; Liu Q; Yu C; Zhang Z; Cai L; Yang B; Qian Y; Yang J; Liao X
Eur J Med Chem; 2017 Nov; 140():349-382. PubMed ID: 28985575
[TBL] [Abstract][Full Text] [Related]
14. Fresh platinum complexes with promising antitumor activity.
Wang X
Anticancer Agents Med Chem; 2010 Jun; 10(5):396-411. PubMed ID: 20545618
[TBL] [Abstract][Full Text] [Related]
15. Meeting report on 8th International Symposium on Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy.
Kelland LR
J Inorg Biochem; 1999 Oct; 77(1-2):121-4. PubMed ID: 10626364
[TBL] [Abstract][Full Text] [Related]
16. The current treatment of recurrent ovarian cancer.
Herzog TJ
Curr Oncol Rep; 2006 Nov; 8(6):448-54. PubMed ID: 17040623
[TBL] [Abstract][Full Text] [Related]
17. Platinum(IV)-nitroxyl complexes as possible candidates to circumvent cisplatin resistance in RT112 bladder cancer cells.
Cetraz M; Sen V; Schoch S; Streule K; Golubev V; Hartwig A; Köberle B
Arch Toxicol; 2017 Feb; 91(2):785-797. PubMed ID: 27307157
[TBL] [Abstract][Full Text] [Related]
18. Update of the Preclinical Situation of Anticancer Platinum Complexes: Novel Design Strategies and Innovative Analytical Approaches.
Galanski MS; Jakupec MA; Keppler BK
Curr Med Chem; 2005; 12(18):2075-94. PubMed ID: 16101495
[TBL] [Abstract][Full Text] [Related]
19. Recurrent epithelial ovarian cancer: pharmacotherapy and novel therapeutics.
Modesitt SC; Jazaeri AA
Expert Opin Pharmacother; 2007 Oct; 8(14):2293-305. PubMed ID: 17927484
[TBL] [Abstract][Full Text] [Related]
20. The role of sulfur in platinum anticancer chemotherapy.
Wang And X; Guo Z
Anticancer Agents Med Chem; 2007 Jan; 7(1):19-34. PubMed ID: 17266503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
